Clinical efficacy and safety of anti PD-1/PD-L1 antibodies as monotherapy in patients with non-small-cell lung cancer

by Marta Zayas-Soriano, Manuel Bonete-Sánchez, Juan Campillo-López, Borja Marcos-Ribes, Ana Hernández-Guio, Mª Teresa Aznar-Saliente
Published 2021-01-01